MedDataX Logo

Translation and Validation of the French Version of Confusion Assessment Method for the Intensive Care Unit

NCT ID: NCT02760446

Last Updated: 2016-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

115 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-11-30

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Validity and Reliability of French Version of the Confusion Assessment Method for the Intensive Care Unit (psychometric validation study after translation/back translation process assessed by the original team : W.Ely, MD, Ph.D, Vanderbilt University)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patients With Mental Confusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CAM-ICU.fr

CAM-ICU and ICDSC evaluation proceed by two investigators and a Neuropsychologist (Speech \& language therapist specialized in neuropsychology)

Group Type OTHER

CAM-ICU.fr

Intervention Type BEHAVIORAL

Neuropsychological testing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CAM-ICU.fr

Neuropsychological testing

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult, \> or equal to 18-yr
* Richmond Agitation Sedation Scale (RASS) \> or equal -3
* Francophone

Exclusion Criteria

* Diagnostic of cognitive disorders
* Admission for brain injury
* Psychotic disorders
* Diagnostic of cognitive disorders
* Visual or auditory impairments
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vanderbilt University

OTHER

Sponsor Role collaborator

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GERALD CHANQUES, MD,Ph.D

Role: PRINCIPAL_INVESTIGATOR

University of Montpellier Hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Universitaire Montpellier, Saint Eloi

Montpellier, Languedoc-Roussillon, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9596

Identifier Type: -

Identifier Source: org_study_id